Dr. Jim Weterings
About Dr. Jim Weterings
Dr. Jim Weterings' Professional Title
Dr. Jim Weterings currently holds the position of Vice President Research, RNA Therapeutics & Delivery. His role focuses on advancing research and development in RNA therapeutics and delivery systems.
Dr. Jim Weterings' Educational Background
Dr. Jim Weterings obtained a master’s degree in Organic Chemistry at Leiden University, the Netherlands. He further advanced his expertise by earning a doctoral degree in Bio-Organic Chemistry from the same institution. His academic journey continued with postdoctoral research in Medicinal Chemistry at Vrije Universiteit Amsterdam, the Netherlands.
Dr. Jim Weterings' Research and Industry Experience
Dr. Jim Weterings has an extensive background in the pharmaceutical and biotech industries. He served as a Research Scientist in Chemistry at Cenix BioScience BVBA in Belgium/Germany. He then progressed to roles including Senior and Principal Scientist in Chemistry at Cristal Therapeutics in the Netherlands. Additionally, he held the pivotal role of Principal Scientist in Oligonucleotide Chemistry at AstraZeneca in Sweden.
Dr. Jim Weterings as a Thought Leader and Conference Speaker
Dr. Jim Weterings is recognized as a thought leader in the field of Oligonucleotide Therapeutics. He is frequently invited to speak at conferences, serve as a chairperson, and participate as an expert panel member. His contributions to the field are widely acknowledged and respected.